Study Title
VICTORY: A Pilot Study to Investigate Safety and Efficacy of Weekly Combination of Intravenous Vinblastine with Oral Type II RAF Inhibitor Tovorafenib in Pediatric Patient with Recurrent/ Progressive RAF Altered (non-NF1) Low Grade Gliomas
Protocol ID
VICTORY
Condition/s
Brain and other Central Nervous System (CNS) Tumours
Low Grade Glioma
Low Grade Glioma
Diagnosis Stage
Relapsed/Recurrent
Location
WA
Sponsor
The Hospital for Sick Children
Australian and New Zealand Children's Haematology Oncology Group
Australian and New Zealand Children's Haematology Oncology Group
Links
Trial Status
Open
Sites
Perth Children's Hospital
Study Type
Treatment
Phase
Pilot
Age Eligibility
Up to 25 Years
International registry ID's
NCT06381570
| Study Title | VICTORY: A Pilot Study to Investigate Safety and Efficacy of Weekly Combination of Intravenous Vinblastine with Oral Type II RAF Inhibitor Tovorafenib in Pediatric Patient with Recurrent/ Progressive RAF Altered (non-NF1) Low Grade Gliomas |
|---|---|
| Protocol ID | VICTORY |
| Disease (Sub Disease) | Brain and other Central Nervous System (CNS) Tumours Low Grade Glioma |
| Diagnosis Stage | Relapsed/Recurrent |
| Location | WA |
| Sponsor | The Hospital for Sick Children/ Australian and New Zealand Children's Haematology Oncology Group |
| Links | https://clinicaltrials.gov/study/NCT06381570 |
| Trial Status | Open |
| Trial Open Date | 23/12/2024 |
| Sites | Perth Children's Hospital |
| Study Type | Treatment |
| Phase | Pilot |
| Age Eligibility | Up to 25 Years |
| International registry ID's | NCT06381570 |